NO20014859D0 - Raskt dispergerbare doseringsformer inneholdende fiskegelatin - Google Patents

Raskt dispergerbare doseringsformer inneholdende fiskegelatin

Info

Publication number
NO20014859D0
NO20014859D0 NO20014859A NO20014859A NO20014859D0 NO 20014859 D0 NO20014859 D0 NO 20014859D0 NO 20014859 A NO20014859 A NO 20014859A NO 20014859 A NO20014859 A NO 20014859A NO 20014859 D0 NO20014859 D0 NO 20014859D0
Authority
NO
Norway
Prior art keywords
fish gelatin
dosage forms
composition
forms containing
active ingredient
Prior art date
Application number
NO20014859A
Other languages
English (en)
Other versions
NO330196B1 (no
NO20014859L (no
Inventor
Owen Murray
Michael Hall
Richard Green
Patrick Kearney
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Publication of NO20014859D0 publication Critical patent/NO20014859D0/no
Publication of NO20014859L publication Critical patent/NO20014859L/no
Publication of NO330196B1 publication Critical patent/NO330196B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20014859A 1999-04-08 2001-10-05 Farmasoytisk preparat i hurtigdispergerende doseringsform, samt fremstilling derav og fremgangsmate for a anvende fiskegelatin som baerer i farmasoytisk preparat. NO330196B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9908014.5A GB9908014D0 (en) 1999-04-08 1999-04-08 Pharmaceutical compositions
PCT/US2000/009278 WO2000061117A1 (en) 1999-04-08 2000-04-07 Fast-dispersing dosage forms containing fish gelatin

Publications (3)

Publication Number Publication Date
NO20014859D0 true NO20014859D0 (no) 2001-10-05
NO20014859L NO20014859L (no) 2001-11-19
NO330196B1 NO330196B1 (no) 2011-03-07

Family

ID=10851154

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014859A NO330196B1 (no) 1999-04-08 2001-10-05 Farmasoytisk preparat i hurtigdispergerende doseringsform, samt fremstilling derav og fremgangsmate for a anvende fiskegelatin som baerer i farmasoytisk preparat.

Country Status (28)

Country Link
US (2) US6709669B1 (no)
EP (1) EP1165053B1 (no)
JP (1) JP4838939B2 (no)
KR (1) KR100767076B1 (no)
CN (1) CN1224381C (no)
AT (1) ATE262890T1 (no)
AU (1) AU761439B2 (no)
BR (1) BR0009609A (no)
CA (1) CA2369715C (no)
CZ (1) CZ295324B6 (no)
DE (1) DE60009472T2 (no)
DK (1) DK1165053T3 (no)
ES (1) ES2215645T3 (no)
GB (1) GB9908014D0 (no)
HK (1) HK1039066B (no)
HU (1) HU229892B1 (no)
IL (2) IL145783A0 (no)
IS (1) IS2403B (no)
MX (1) MXPA01010094A (no)
NO (1) NO330196B1 (no)
NZ (1) NZ515230A (no)
PL (1) PL196572B1 (no)
PT (1) PT1165053E (no)
RO (1) RO122011B1 (no)
RU (1) RU2242969C2 (no)
TR (1) TR200102881T2 (no)
WO (1) WO2000061117A1 (no)
ZA (1) ZA200109089B (no)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB9910505D0 (en) * 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
EP1238675A1 (en) * 2001-03-06 2002-09-11 Fuji Photo Film B.V. Recombinant gelatin-like proteins for use as plasma expanders
DE60200861T2 (de) * 2001-07-02 2005-08-04 Bioprogress S.P.A. Verwendungen einer Zusammensetzung enthaltend teilweise hydrolysiertes Fischgelatin
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
KR100425226B1 (ko) * 2001-07-03 2004-03-30 주식회사 팜트리 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
NZ535861A (en) * 2002-05-07 2006-11-30 Ferring Bv Desmopressin acetate in an orodispersible dosage form that disintegrates in the mouth within 10 seconds
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
AU2003280324A1 (en) * 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
UA93479C2 (en) * 2002-11-26 2011-02-25 Альк-Абелло A/C Allergen dosage form
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
MXPA05009079A (es) 2003-02-28 2006-05-19 Alk Abello As Forma de dosificacion que tiene una matriz de sacarido.
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
EP1689419A4 (en) 2003-11-10 2009-01-14 Reprise Biopharmaceutics Llc PHARMACEUTICAL COMPOSITIONS WITH LOW DOSES OF DESMOPRESSIN
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
EP1530967B1 (en) 2003-11-13 2006-05-03 Ferring B.V. Blister pack and solid dosage form comprising desmopressin
US9241902B2 (en) 2003-12-17 2016-01-26 R.P. Scherer Technologies, Llc Chewable soft capsules containing ungelatinized starch
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
WO2006058250A2 (en) * 2004-11-24 2006-06-01 Spi Pharma, Inc. Orally disintegrating compositions
MX2007007885A (es) * 2004-12-23 2007-10-04 Johnson & Johnson Composiciones farmaceuticas oralmente desintegrables con agentes de indicacion sensorial.
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
GB0510286D0 (en) * 2005-05-19 2005-06-29 Kilda Biolink As Composition
EA023884B1 (ru) * 2005-05-19 2016-07-29 Аква Био Текнолоджи Аса Содержащая желатин композиция для наружного применения и способы ее использования
WO2007143676A2 (en) * 2006-06-05 2007-12-13 Verus Pharmaceuticals, Inc. Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
TW200815048A (en) * 2006-06-05 2008-04-01 Verus Pharmaceuticals Inc Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
EP2043613A1 (en) * 2006-07-14 2009-04-08 Fmc Corporation Solid form
TWI343262B (en) * 2006-09-26 2011-06-11 Schering Corp Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
US20090214442A1 (en) * 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
WO2008069921A2 (en) * 2006-12-01 2008-06-12 Cima Labs Inc. Oral transmucosal nicotine dosage form
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
ES2612032T3 (es) * 2007-06-04 2017-05-11 Shear/Kershman Laboratories, Inc. Formas farmacéuticas orales basadas en lípidos inviolables para agonistas opiáceos
US20090004231A1 (en) * 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
KR100905027B1 (ko) * 2007-10-03 2009-06-30 (주)씨엘팜 식용 필름
GB2453770A (en) 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
RU2010139643A (ru) * 2008-02-28 2012-04-10 Ар.Пи. ШЕРЕР ТЕКНОЛОДЖИЗ, ЭлЭлСи к/о СиЭсСи Сервисиз оф Невада, Инк., (US) Способ минимизации полиморфизма
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
NO2296686T3 (no) 2008-05-21 2014-07-12
US8420700B1 (en) * 2008-06-04 2013-04-16 James M. Bausch Tamper resistant lipid-based oral dosage form for sympathomimetic amines
EP3572073B1 (en) * 2008-08-05 2023-12-20 Wyeth LLC Lyophilization above collapse
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
TWI471127B (zh) 2009-04-29 2015-02-01 Intervet Int Bv 供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物
PT2442821T (pt) 2009-06-18 2017-09-29 Allergan Inc Administração segura de desmopressina
US8545879B2 (en) * 2009-08-31 2013-10-01 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam
US9775819B2 (en) * 2009-09-16 2017-10-03 R.P. Scherer Technologies, Llc Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
PL2493457T3 (pl) 2009-10-30 2018-01-31 Ix Biopharma Ltd Szybko rozpuszczalna stała postać dawkowana
US10548839B2 (en) * 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
NZ706991A (en) 2010-03-29 2016-08-26 Ferring Bv A fast dissolving pharmaceutical composition
EP3095441B1 (en) * 2010-10-08 2020-12-02 R.P. Scherer Technologies, LLC Oral vaccine fast-dissolving dosage form using starch
JP2012121850A (ja) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
WO2012106058A2 (en) * 2011-01-31 2012-08-09 New Market Pharmaceuticals Animal treatments
JP2011116764A (ja) * 2011-02-08 2011-06-16 Fine Seymour H 低用量デスモプレシンを含有する医薬組成物
MX345674B (es) 2011-09-16 2017-02-10 Ferring Bv Composicion farmaceutica de disolucion rapida.
WO2013165468A1 (en) 2012-05-02 2013-11-07 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
JP2015172084A (ja) * 2015-07-06 2015-10-01 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
CN107397208B (zh) * 2016-07-20 2021-05-07 吴登成 以鱼鳔胶为主成分的功能食品及其用途
CA3040422A1 (en) 2016-10-13 2018-04-19 Catalent U.K. Swindon Zydis Limited Lyophilized pharmaceutical compositions for vaginal delivery
WO2018078548A1 (en) 2016-10-25 2018-05-03 Catalent U.K. Swindon Zydis Limited Compositions of different densities for fast disintegrating multi-layer tablet
EP4371554A2 (en) 2016-12-31 2024-05-22 BioXcel Therapeutics, Inc. Use of sublingual dexmedetomidine for the treatment of agitation
CN110049757A (zh) 2017-01-11 2019-07-23 辉凌公司 快速崩解的药物组合物
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
US10517834B2 (en) * 2017-05-16 2019-12-31 Owen Murray Fast dissolving tablet formulations and methods of making thereof
CN110944641A (zh) * 2017-06-20 2020-03-31 西雅图咖米公司 明胶胶粘组合物及其制造和使用方法
AU2019229784A1 (en) 2018-03-08 2020-08-13 Catalent U.K. Swindon Zydis Limited Process to reduce endotoxin in gelatin
AU2019242604A1 (en) * 2018-03-25 2020-10-22 Pfizer Ireland Pharmaceuticals Rimegepant for CGRP related disorders
MX2020012377A (es) * 2018-05-27 2021-04-12 Biohaven Therapeutics Ltd Uso de tabletas de desintegracion orales de riluzol para el tratamiento de enfermedades.
CN115154440A (zh) 2018-06-27 2022-10-11 比奥克斯塞尔医疗股份有限公司 含右美托咪定的膜制剂及其制造方法
SG11202100880VA (en) 2018-08-16 2021-02-25 Biohaven Therapeutics Ltd Use of riluzole oral disintigrating tablets for treating diseases
EP3911409A4 (en) * 2019-01-20 2022-10-19 Biohaven Pharmaceutical Holding Company Ltd. CGRP ANTAGONISTS FOR TREATMENT OF BREAKTHROUGHT MIGRAINE
AU2020225818A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated API particles produced by solventless mixing processes in aqueous suspension
GB2585414B (en) 2019-02-22 2023-06-14 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
GB2597579B (en) 2019-02-22 2023-04-26 Catalent Uk Swindon Zydis Ltd Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
AU2020224375A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Minimizing aeration of suspensions during in-line mixing
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
AR123109A1 (es) 2020-07-31 2022-10-26 Catalent Uk Swindon Zydis Ltd Composiciones farmacéuticas que comprenden ifa
WO2022058556A1 (en) 2020-09-17 2022-03-24 Catalent U.K. Swindon Zydis Limited Use of surfactant with high molecular weight fish gelatin based dosage formulations to improve flow characteristics
CA3198547A1 (en) * 2020-11-16 2022-05-19 Mark RIDALL Rapidly infusing platform and compositions for therapeutic treatment in humans
US11672761B2 (en) * 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2022179635A1 (zh) * 2021-02-27 2022-09-01 北京兴源联合医药科技有限公司 一种β-烟酰胺单核苷酸冻干口服制剂
BR112023025552A2 (pt) 2021-06-11 2024-02-27 Orphai Therapeutics Inc Composições estabilizadas de apilimod e usos das mesmas
IL310591A (en) * 2021-08-19 2024-04-01 Mind Medicine Inc Lyophilized orally disintegrating tablet formulations of d-lysergic acid diethylamide for therapeutic applications
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US4139497A (en) * 1977-04-04 1979-02-13 The Dow Chemical Company Dehydrogenation catalyst tablet and method for making same
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US5035896A (en) * 1988-06-15 1991-07-30 Warner-Lambert Company Water insoluble drugs coated by coacervated fish gelatin
MC2034A1 (fr) * 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
IL87344A (en) 1988-08-04 1992-03-29 Univ Bar Ilan Process for the production of gelatin from fish skins
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US4946684A (en) 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
ES2097155T3 (es) 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
WO1992002133A1 (en) 1990-08-10 1992-02-20 Analytical Control Systems, Inc. Improved diagnostic and therapeutic compositions
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
DE69220080T2 (de) * 1991-10-11 1997-12-11 Abbott Lab Reagenzzusammensetzung in form von benutzer-einheiten für spezifische bindungstests
KR100256147B1 (ko) 1991-12-24 2000-08-01 오노다 마사요시 구강내 붕해성 제제 및 이의 제조방법
ATE147261T1 (de) 1992-01-13 1997-01-15 Pfizer Verfahren zur herstellung von tabletten mit hoher festigkeit
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
ES2162867T3 (es) * 1993-07-09 2002-01-16 Scherer Corp R P Metodo de fabricacion de formas de dosificacion de farmacos liofilizados.
US5382437A (en) 1993-10-25 1995-01-17 Hunter Research Corporation Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5484888A (en) 1994-03-08 1996-01-16 Holzer; David Gelatin production
US5603952A (en) 1994-12-30 1997-02-18 Tastemaker Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom
GB9517062D0 (en) 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
DK0893992T3 (da) 1996-04-16 2004-06-01 Novartis Consumer Health Sa Hurtigt sönderdelende oral doseringsform
US5879796A (en) * 1996-09-05 1999-03-09 E. I. Du Pont De Nemours And Company Organic/inorganic particulates
US6071963A (en) 1996-11-06 2000-06-06 Roche Vitamins Inc. Water dispersible compositions
NZ337843A (en) * 1997-04-03 2001-11-30 Bridge Pharma Inc Benzocycloheptathiophene compounds
FR2766089B1 (fr) 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6077540A (en) 1997-08-08 2000-06-20 Bayer Corporation Gelatin spray coating
US6020003A (en) * 1998-02-23 2000-02-01 Basf Corporation Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US7972621B2 (en) 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight

Also Published As

Publication number Publication date
ZA200109089B (en) 2003-04-30
AU761439B2 (en) 2003-06-05
MXPA01010094A (es) 2002-05-06
US6709669B1 (en) 2004-03-23
TR200102881T2 (tr) 2002-05-21
HU229892B1 (en) 2014-11-28
CZ20013588A3 (cs) 2002-06-12
KR100767076B1 (ko) 2007-10-17
IS2403B (is) 2008-09-15
PT1165053E (pt) 2004-06-30
JP4838939B2 (ja) 2011-12-14
CA2369715C (en) 2006-03-21
PL196572B1 (pl) 2008-01-31
HUP0201877A3 (en) 2004-05-28
WO2000061117A1 (en) 2000-10-19
EP1165053A1 (en) 2002-01-02
NO330196B1 (no) 2011-03-07
CN1350450A (zh) 2002-05-22
RO122011B1 (ro) 2008-11-28
DE60009472T2 (de) 2004-12-23
HUP0201877A2 (hu) 2002-11-28
NO20014859L (no) 2001-11-19
DK1165053T3 (da) 2004-06-01
RU2242969C2 (ru) 2004-12-27
HK1039066A1 (en) 2002-04-12
BR0009609A (pt) 2002-02-13
PL354958A1 (en) 2004-03-22
EP1165053A4 (en) 2002-06-12
IL145783A (en) 2006-10-31
EP1165053B1 (en) 2004-03-31
ATE262890T1 (de) 2004-04-15
CZ295324B6 (cs) 2005-07-13
IS6102A (is) 2001-10-04
DE60009472D1 (de) 2004-05-06
NZ515230A (en) 2004-01-30
CA2369715A1 (en) 2000-10-19
IL145783A0 (en) 2002-07-25
JP2003524622A (ja) 2003-08-19
ES2215645T3 (es) 2004-10-16
US20040076666A1 (en) 2004-04-22
US9192580B2 (en) 2015-11-24
GB9908014D0 (en) 1999-06-02
KR20020000160A (ko) 2002-01-04
CN1224381C (zh) 2005-10-26
AU4333100A (en) 2000-11-14
HK1039066B (zh) 2004-08-13

Similar Documents

Publication Publication Date Title
NO20014859D0 (no) Raskt dispergerbare doseringsformer inneholdende fiskegelatin
ATE340563T1 (de) DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT
EE03805B1 (et) Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
DE69940674D1 (de) Orale verabreichung von adenosin analogen
TWI235068B (en) Sustained-release pharmaceutical composition
HUP0104031A2 (hu) Új eljárás mikrokapszulázott készítmények előállítására
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
ATE345782T1 (de) Dosierungsformen enthaltend geschmacksmaskierten wirkstoffen
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
HUP0301349A2 (hu) IL-11-tartalmú készítmények
SE9700885D0 (sv) New pharmaceutical formulation
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
AP1736A (en) Oral dosage form for controlled drug release.
HUP9902559A2 (hu) Paracetamolt és drotavenint tartalmazó gyógyszerkészítmény és eljárás előállítására

Legal Events

Date Code Title Description
MK1K Patent expired